We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Comprehensive New Diagnostic Technology Research Partnership Announced

By MedImaging International staff writers
Posted on 11 Jul 2016
Print article
A comprehensive agreement for research collaboration on Artificial Intelligence (AI) applications for emergency stroke care applications has been announced.

The AI and deep learning applications will be trained using medical imaging and anonymized patient data from hospital Electronic Medical Record (EMR) systems. The applications will use data archives from all major modalities.

MedyMatch Technology (Andover, MA, USA), a data analytics healthcare company announced the partnership with Capital Health (Pennington, NJ, USA). MedyMatch Technology uses artificial intelligence and cognitive analytics to create real-time decision support tools for use in emergency medicine. The goal of the partnership is to develop a decision support tool to improve outcomes for stroke patients. MedyMatch Technology also announced that this is the first in a series of planned partnerships in the US.

Gene Saragnese, chairman and CEO of MedyMatch Technology, said, "MedyMatch is excited to be working with a leading institution like Capital Health which offers advanced radiology services that help support the critical diagnostics needed for its comprehensive stroke center. True innovation in healthcare only comes from the close collaboration between industry and world-class clinicians. Our partnership with Capital Health brings together breakthrough technology in deep learning and clinical expertise that will accelerate the transformation we all desire in healthcare, better care at lower cost. Having access to an archive of anonymized medical imaging data, and understanding the patient outcomes, represents an unprecedented opportunity for the MedyMatch artificial intelligence to self-learn, auto label and tag, hundreds of diseases."

Related Links:
MedyMatch Technology
Capital Health
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Color Doppler Ultrasound System
DRE Crystal 4PX
Ultrasound Software
UltraExtend NX
New
Wireless Handheld Ultrasound System
TE Air

Print article
Radcal

Channels

MRI

view channel
Image: Diamond dust offers a potential alternative to the widely used contrast agent gadolinium in MRI (Photo courtesy of Max Planck Institute)

Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans

Gadolinium, a heavy metal used for over three decades as a contrast agent in medical imaging, enhances the clarity of MRI scans by highlighting affected areas. Despite its utility, gadolinium not only... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.